Cargando…
N-[(11)C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs
PURPOSE: Chemokine receptor 4 (CXCR4) is overexpressed in many cancers and a potential drug target. We have recently developed the tracer N-[(11)C]methyl-AMD3465 for imaging of CXCR4 expression by positron emission tomography (PET). We investigated the pharmacokinetics of N-[(11)C]methyl-AMD3465 in...
Autores principales: | Hartimath, S. V., Khayum, M. A., van Waarde, A., Dierckx, R. A. J. O., de Vries, E. F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498639/ https://www.ncbi.nlm.nih.gov/pubmed/27896627 http://dx.doi.org/10.1007/s11307-016-1028-8 |
Ejemplares similares
-
Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[(11)C]Methyl-AMD3465 PET
por: Hartimath, SV, et al.
Publicado: (2019) -
The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
por: Ling, Xiaoyang, et al.
Publicado: (2013) -
The Effects of the CXCR4 Antagonist, AMD3465, on Human Retinal Vascular Endothelial Cells (hRVECs) in a High Glucose Model of Diabetic Retinopathy
por: Wu, Di, et al.
Publicado: (2019) -
AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015) -
PET Imaging with S-[(11)C]Methyl-L-Cysteine and L-[Methyl-(11)C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
por: Parente, Andrea, et al.
Publicado: (2017)